ACU
Acme United Corporation41.84
+1.04+2.55%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
159.27MP/E (TTM)
17.08Basic EPS (TTM)
2.45Dividend Yield
0.02%Recent Filings
10-Q
Q3 FY2025 results
Acme United nudged Q3 sales up 2% y/y to $49.1M, driven by first aid gains in Canada (up 5%) and Europe (up 13%), while U.S. edged 1% higher despite school product order cuts from tariff jitters. Gross margins lifted to 39.1% from 38.5%, but SG&A climbed, holding operating income steady at $3.0M; diluted EPS dipped to $0.46 from $0.54 on higher shares, matching YTD $2.03 flat y/y with 4,091k diluted shares. Cash from operations hit $10.1M, funding $9.8M capex including a $6M TN facility buy, with FCF at $0.3M (derived). Debt steady near $28M under $65M SOFR+1.75% revolver (to 2027, compliant) plus 3.8% mortgage to 2031, cash at $5.1M. Tariffs still squeeze costs.
8-K
Q3 sales up 2%, income dips
Acme United posted a 2% rise in Q3 net sales to $49.1 million, fueled by 9% growth in first aid revenues from online and refill channels, yet Westcott cutting tools suffered from tariff-driven promotion cancellations. Operating income climbed 3% to $3.0 million, with gross margins expanding to 39.1%, while net income dipped 14% to $1.9 million due to a higher 22% tax rate versus last year's 8%. Debt net of cash fell to $23.1 million. Tariff uncertainties linger.
10-Q
Q2 FY2025 results
Acme United's Q2 net sales dipped 3% y/y to $54.0M, yet operating income held steady at $6.4M while gross margins edged up to 41.0% from 40.8%, thanks to cost controls amid softer U.S. demand from tariffs and delayed orders. Canada surged 28% y/y on strong first aid sales, offsetting a 3% European dip; YTD, revenue fell 0.3% y/y to $100.0M with operating income down 1.3% to $8.8M, but diluted EPS climbed 7% y/y to $1.57 on 4,070K shares. Cash from operations hit $3.0M, yielding $74K free cash flow after $3.0M capex (derived), while debt eased to $26.7M with $48.6M revolver availability and covenant compliance. The May 2024 Elite First Aid asset buy for $7.1M (cash, $0.5M contingent) bolsters tactical medical offerings. Tariffs on Chinese imports pose ongoing supply chain risks.
8-K
Record Q2 net income
Acme United posted record Q2 2025 net income of $4.8 million, up 7% from $4.5 million last year, despite a 3% sales dip to $54.0 million amid tariff-driven order cancellations. Gross margins edged up to 41.0%, buoyed by diversified sourcing from U.S. and Canadian acquisitions, while Canada sales surged 28% on first-aid demand. Net debt fell to $22.8 million. Tariffs persist as a key risk.
8-K
Credit facility extended one year
Acme United Corporation extended its $65 million secured revolving credit facility with HSBC Bank USA, N.A., pushing the maturity from May 31, 2026, to May 31, 2027, effective June 26, 2025. All other terms stay the same, providing an extra year of liquidity without added costs. This straightforward rollover signals steady banking ties. No new risks emerge from the amendment.
IPO
Website
Employees
Sector
Industry
ACCO
Acco Brands Corporation
3.77-0.02
ACTG
Acacia Research Corporation
3.83+0.05
CL
Colgate-Palmolive Company
78.95-0.48
CLX
Clorox Company (The)
99.82-1.90
HELE
Helen of Troy Limited
20.35-0.54
NWL
Newell Brands Inc.
3.77+0.00
PG
Procter & Gamble Company (The)
145.21+0.08
SPB
Spectrum Brands Holdings, Inc.
60.20-1.38
UEEC
United Health Products, Inc.
0.06+0.00
UL
Unilever PLC
64.33-0.71